Tiziana Life Sciences Ltd TLSA
- foralumab — Non-Active Secondary Progressive Multiple Sclerosis Phase 2
- foralumab — Alzheimer's Disease Phase 2
- foralumab — Amyotrophic Lateral Sclerosis Phase 2
- foralumab — Multiple System Atrophy Phase 2
CD3 epsilon (1 companies · 4 programs)
Companies with an active program directed at CD3 epsilon.